Table 1A

Number of subjects included in the study

Sex6 M/2 F10 M/8 F9 M/7 F
Age6 months (2–12 months)3 months (1 week to 14 months)3 months (21 weeks to 16 months)
Time on treatment6 months (2 weeks to 12 months)
  • Clinical and epidemiological data of the subjects included in the study.

  • Values are reported as median (IQR). No significant differences were detected according to age (p=0.165).

  • CMV, cytomegalovirus; CTL, control; F, females; M, males; UT, untreated; VAL, valganciclovir.